Description and Brand Names
Drug information provided by: IBM Micromedex
Nirmatrelvir and ritonavir combination is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk for progression to severe COVID-19 (eg, hospitalization, death).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: March 01, 2023
Copyright © 2023 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.